| |
| |
|
| Insider
Information: |
Prout Samantha |
| Relationship: |
|
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
73,926 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$784,355 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
73,926 |
|
|
| Total
Value |
$784,355 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
|
2024-04-15 |
73,926 |
2019-01-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Principal Accounting Officer |
• – – |
2021-04-15 |
4 |
D |
$10.33 |
$6,818 |
D/D |
(660) |
88,215 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Principal Accounting Officer |
• – – |
2021-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
24,201 |
88,875 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-12-31 |
4 |
D |
$14.19 |
$331,422 |
D/D |
(23,356) |
98,556 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Accounting Officer |
• – – |
2024-01-04 |
4 |
D |
$13.44 |
$17,418 |
D/D |
(1,296) |
113,057 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Accounting Officer |
• – – |
2024-01-03 |
4 |
D |
$13.53 |
$110,161 |
D/D |
(8,142) |
114,353 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-12-26 |
4 |
S |
$14.00 |
$107,228 |
D/D |
(7,659) |
121,912 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Accounting Officer |
• – – |
2024-01-02 |
4 |
D |
$14.24 |
$18,697 |
D/D |
(1,313) |
122,495 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Accounting Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,252 |
123,808 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-08-17 |
4 |
D |
$12.77 |
$94,907 |
D/D |
(7,432) |
129,571 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Accounting OfficerOffice |
• – – |
2023-07-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
137,003 |
|
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-08-09 |
4 |
S |
$14.01 |
$516,933 |
D/D |
(36,909) |
137,003 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Accounting Officer |
• – – |
2023-08-09 |
4 |
OE |
$9.55 |
$407,116 |
D/D |
36,909 |
173,912 |
0 |
- |
|
37 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
